Financials: United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

90.94USD
31 Jul 2014
Price Change (% chg)

$-2.35 (-2.52%)
Prev Close
$93.29
Open
$92.72
Day's High
$92.92
Day's Low
$89.37
Volume
249,831
Avg. Vol
275,553
52-wk High
$116.42
52-wk Low
$70.62

Search Stocks

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2014 Jun '14 322.80 2.100
Mar '14 289.40 2.430
FY 2013 Dec '13 289.02 -0.603
Sep '13 302.23 1.168
Jun '13 280.61 1.517
Mar '13 245.14 1.190
FY 2012 Dec '12 243.82 1.614
Sep '12 242.47 1.458
Jun '12 225.58 1.341
Mar '12 204.21 1.286
 
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-14 14 333.54 351.70 302.60 290.20
Quarter Ending Dec-14 14 336.80 353.39 309.80 287.00
Year Ending Dec-14 14 1,286.76 1,371.20 1,231.52 1,151.85
Year Ending Dec-15 14 1,425.23 1,604.40 1,202.33 1,178.81
EARNINGS (per share)
Quarter Ending Sep-14 13 1.93 3.11 1.56 1.30
Quarter Ending Dec-14 13 1.97 2.96 1.60 1.78
Year Ending Dec-14 13 8.38 9.38 7.82 7.14
Year Ending Dec-15 13 9.10 10.68 7.93 6.85

Sales and Earnings Figures in U.S. Dollars (USD)

Valuation Ratios

  Company Industry Sector
P/E Ratio (TTM) 17.85 102.69 36.20
P/E High - Last 5 Yrs. 152.99 109.48 40.13
P/E Low - Last 5 Yrs. 9.35 89.78 14.12
Beta 1.32 1.13 0.81
Price to Sales (TTM) 3.57 129.03 5.80
Price to Book (MRQ) -- 8.69 6.65
Price to Tangible Book (MRQ) -- 9.88 7.63
Price to Cash Flow (TTM) 13.76 65.36 28.20
Price to Free Cash Flow (TTM) -- 14.26 11.70
% Owned Institutions -- -- --

Dividends

  Company Industry Sector
Dividend Yield -- 0.54 1.43
Dividend Yield - 5 Year Avg. 0.00 0.66 1.53
Dividend 5 Year Growth Rate -- 4.18 29.88
Payout Ratio(TTM) 0.00 11.42 15.04

Growth Rates

  Company Industry Sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.04 60.22 14.57
Sales (TTM) vs TTM 1 Yr. Ago 18.91 32.38 14.97
Sales - 5 Yr. Growth Rate 31.74 24.78 12.74
EPS (MRQ) vs Qtr. 1 Yr. Ago 38.46 -45.20 10.75
EPS (TTM) vs TTM 1 Yr. Ago -11.83 -- --
EPS - 5 Yr. Growth Rate -- 11.10 15.77
Capital Spending - 5 Yr. Growth Rate -23.83 12.72 20.45

Financial Strength

  Company Industry Sector
Quick Ratio (MRQ) -- 4.09 2.10
Current Ratio (MRQ) -- 11.81 3.07
LT Debt to Equity (MRQ) -- 19.56 6.57
Total Debt to Equity (MRQ) -- 26.72 13.36
Interest Coverage (TTM) 29.98 4.16 21.24

Profitability Ratios

  Company Industry Sector
Gross Margin (TTM) 88.47 29.84 53.61
Gross Margin - 5 Yr. Avg. 87.99 44.00 53.09
EBITD Margin (TTM) 41.48 -- --
EBITD - 5 Yr. Avg 36.42 -348.57 16.93
Operating Margin (TTM) 38.94 -329.48 10.76
Operating Margin - 5 Yr. Avg. 32.97 -373.22 12.93
Pre-Tax Margin (TTM) 37.87 -365.95 10.10
Pre-Tax Margin - 5 Yr. Avg. 31.99 -183.88 14.53
Net Profit Margin (TTM) 23.41 -365.26 6.25
Net Profit Margin - 5 Yr. Avg. 22.18 -183.05 10.37
Effective Tax Rate (TTM) 38.19 28.76 24.87
Effective Tax Rate - 5 Yr. Avg. 30.67 16.84 25.64

Efficiency

  Company Industry Sector
Revenue/Employee (TTM) 1,704,599 9,973,818 917,727,978
Net Income/Employee (TTM) 399,075 -2,087,122 108,831,955
Receivable Turnover (TTM) -- 14.20 6.62
Inventory Turnover (TTM) -- 6.04 3.88
Asset Turnover (TTM) -- 0.50 1.16

Management Effectiveness

  Company Industry Sector
Return on Assets (TTM) -- -110.31 1.96
Return on Assets - 5 Yr. Avg. 11.63 -4.92 14.30
Return on Investment (TTM) -- -0.51 18.07
Return on Investment - 5 Yr. Avg. 14.80 -6.09 19.12
Return on Equity (TTM) -- -1.55 18.86
Return on Equity - 5 Yr. Avg. 18.18 -12.11 19.79
  1 Year 3 Years 5 Years
Sales % 21.93 23.51 31.74
EPS % -42.61 20.62 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for United Therapeutics Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.40 3.25 77 18
13 Week -11.02 -13.18 40 82
26 Week -14.47 -20.52 47 12
52 Week 21.37 5.97 55 50
YTD -19.58 -23.01 31 21
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 416
Total Shares Held: 54,255,741
3 Mo. Net Change: -571,608
# New Positions: 10
# Closed Positions: 12
# Increased Positions: 28
# Reduced Positions: 40
# Net Buyers: -12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Search Stocks